COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Fundamental Analysis & Valuation

NYSE:CRBD • US21871X2080

Current stock price

23.75 USD
+0.11 (+0.47%)
Last:

This CRBD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CRBD Profitability Analysis

1.1 Basic Checks

  • In the past year CRBD was profitable.
  • In the past year CRBD had a positive cash flow from operations.
  • Of the past 5 years CRBD 4 years were profitable.
  • CRBD had a positive operating cash flow in each of the past 5 years.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

1.2 Ratios

  • CRBD has a Return On Assets of -0.09%. This is in the lower half of the industry: CRBD underperforms 71.72% of its industry peers.
  • CRBD's Return On Equity of -2.77% is on the low side compared to the rest of the industry. CRBD is outperformed by 73.74% of its industry peers.
  • CRBD has a Return On Invested Capital of 0.17%. This is in the lower half of the industry: CRBD underperforms 66.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CRBD is significantly below the industry average of 8.00%.
Industry RankSector Rank
ROA -0.09%
ROE -2.77%
ROIC 0.17%
ROA(3y)0.26%
ROA(5y)0.96%
ROE(3y)8.69%
ROE(5y)28.02%
ROIC(3y)0.34%
ROIC(5y)0.97%
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1.3 Margins

  • Looking at the Operating Margin, with a value of 4.92%, CRBD is doing worse than 61.62% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CRBD has declined.
  • The Profit Margin and Gross Margin are not available for CRBD so they could not be analyzed.
Industry RankSector Rank
OM 4.92%
PM (TTM) N/A
GM N/A
OM growth 3Y-51.36%
OM growth 5Y-12.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

3

2. CRBD Health Analysis

2.1 Basic Checks

  • CRBD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CRBD has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CRBD has less shares outstanding
  • CRBD has a better debt/assets ratio than last year.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B

2.2 Solvency

  • CRBD has a debt to FCF ratio of 5.40. This is a neutral value as CRBD would need 5.40 years to pay back of all of its debts.
  • CRBD has a better Debt to FCF ratio (5.40) than 63.64% of its industry peers.
  • CRBD has a Debt/Equity ratio of 0.83. This is a neutral value indicating CRBD is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CRBD (0.83) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.4
Altman-Z N/A
ROIC/WACC0.02
WACC6.82%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

3

3. CRBD Growth Analysis

3.1 Past

  • The earnings per share for CRBD have decreased by -2.89% in the last year.
  • Looking at the last year, CRBD shows a decrease in Revenue. The Revenue has decreased by -0.26% in the last year.
  • The Revenue has been growing slightly by 4.89% on average over the past years.
EPS 1Y (TTM)-2.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.81%
Revenue 1Y (TTM)-0.26%
Revenue growth 3Y-11.53%
Revenue growth 5Y4.89%
Sales Q2Q%26.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.00% on average over the next years. This is quite good.
  • Based on estimates for the next years, CRBD will show a small growth in Revenue. The Revenue will grow by 6.21% on average per year.
EPS Next Y11.22%
EPS Next 2Y13.2%
EPS Next 3Y12.7%
EPS Next 5Y12%
Revenue Next Year9.38%
Revenue Next 2Y7.5%
Revenue Next 3Y6%
Revenue Next 5Y6.21%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

8

4. CRBD Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 5.05 indicates a rather cheap valuation of CRBD.
  • 91.92% of the companies in the same industry are more expensive than CRBD, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, CRBD is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 4.54, the valuation of CRBD can be described as very cheap.
  • 92.93% of the companies in the same industry are more expensive than CRBD, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.62, CRBD is valued rather cheaply.
Industry RankSector Rank
PE 5.05
Fwd PE 4.54
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRBD.
  • Based on the Price/Free Cash Flow ratio, CRBD is valued cheaply inside the industry as 94.95% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.37
EV/EBITDA 14.84
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • CRBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CRBD's earnings are expected to grow with 12.70% in the coming years.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y13.2%
EPS Next 3Y12.7%

3

5. CRBD Dividend Analysis

5.1 Amount

  • CRBD has a Yearly Dividend Yield of 3.73%.
  • CRBD's Dividend Yield is rather good when compared to the industry average which is at 1.82. CRBD pays more dividend than 84.85% of the companies in the same industry.
  • CRBD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.73%

5.2 History

  • CRBD is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • CRBD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-139.62%
EPS Next 2Y13.2%
EPS Next 3Y12.7%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

CRBD Fundamentals: All Metrics, Ratios and Statistics

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (4/24/2026, 4:15:00 PM)

23.75

+0.11 (+0.47%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-09
Earnings (Next)05-04
Inst Owners95.42%
Inst Owner ChangeN/A
Ins Owners0.3%
Ins Owner ChangeN/A
Market Cap10.85B
Revenue(TTM)17.80B
Net Income(TTM)-366.00M
Analysts79.05
Price Target35.22 (48.29%)
Short Float %0.01%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield 3.73%
Yearly Dividend0.97
Dividend Growth(5Y)N/A
DP-139.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.99%
Min EPS beat(2)-13.79%
Max EPS beat(2)7.82%
EPS beat(4)2
Avg EPS beat(4)2.28%
Min EPS beat(4)-13.79%
Max EPS beat(4)15.55%
EPS beat(8)6
Avg EPS beat(8)3.56%
EPS beat(12)9
Avg EPS beat(12)4.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.37%
Min Revenue beat(2)15.74%
Max Revenue beat(2)23.01%
Revenue beat(4)2
Avg Revenue beat(4)3.85%
Min Revenue beat(4)-11.92%
Max Revenue beat(4)23.01%
Revenue beat(8)3
Avg Revenue beat(8)-6.11%
Revenue beat(12)5
Avg Revenue beat(12)-5.65%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.42%
PT rev (3m)15.15%
EPS NQ rev (1m)-2.59%
EPS NQ rev (3m)-3.81%
EPS NY rev (1m)-0.84%
EPS NY rev (3m)-2.76%
Revenue NQ rev (1m)-0.37%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)1.21%
Valuation
Industry RankSector Rank
PE 5.05
Fwd PE 4.54
P/S 0.61
P/FCF 5.37
P/OCF 5.37
P/B 0.82
P/tB 0.82
EV/EBITDA 14.84
EPS(TTM)4.7
EY19.79%
EPS(NY)5.23
Fwd EY22.01%
FCF(TTM)4.42
FCFY18.63%
OCF(TTM)4.42
OCFY18.63%
SpS38.97
BVpS28.9
TBVpS28.9
PEG (NY)0.45
PEG (5Y)N/A
Graham Number55.2858 (132.78%)
Profitability
Industry RankSector Rank
ROA -0.09%
ROE -2.77%
ROCE 0.21%
ROIC 0.17%
ROICexc 0.17%
ROICexgc 0.24%
OM 4.92%
PM (TTM) N/A
GM N/A
FCFM 11.35%
ROA(3y)0.26%
ROA(5y)0.96%
ROE(3y)8.69%
ROE(5y)28.02%
ROIC(3y)0.34%
ROIC(5y)0.97%
ROICexc(3y)0.34%
ROICexc(5y)0.97%
ROICexgc(3y)0.5%
ROICexgc(5y)1.47%
ROCE(3y)0.43%
ROCE(5y)1.25%
ROICexgc growth 3Y-59.3%
ROICexgc growth 5Y-9.14%
ROICexc growth 3Y-58.91%
ROICexc growth 5Y-8.46%
OM growth 3Y-51.36%
OM growth 5Y-12.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.4
Debt/EBITDA 7.62
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.5
Cash Conversion 141.13%
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC6.82%
ROIC/WACC0.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.81%
EPS Next Y11.22%
EPS Next 2Y13.2%
EPS Next 3Y12.7%
EPS Next 5Y12%
Revenue 1Y (TTM)-0.26%
Revenue growth 3Y-11.53%
Revenue growth 5Y4.89%
Sales Q2Q%26.42%
Revenue Next Year9.38%
Revenue Next 2Y7.5%
Revenue Next 3Y6%
Revenue Next 5Y6.21%
EBIT growth 1Y-72.38%
EBIT growth 3Y-56.97%
EBIT growth 5Y-8.3%
EBIT Next Year33.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.04%
FCF growth 3Y-9.15%
FCF growth 5Y-9.49%
OCF growth 1Y-6.04%
OCF growth 3Y-9.15%
OCF growth 5Y-9.49%

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 / CRBD Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64?

ChartMill assigns a fundamental rating of 3 / 10 to CRBD.


What is the valuation status for CRBD stock?

ChartMill assigns a valuation rating of 8 / 10 to COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD). This can be considered as Undervalued.


How profitable is COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) has a profitability rating of 2 / 10.


What is the expected EPS growth for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

The Earnings per Share (EPS) of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is expected to grow by 11.22% in the next year.


How sustainable is the dividend of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

The dividend rating of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is 3 / 10 and the dividend payout ratio is -139.62%.